α-半乳糖综合征患者对医疗产品的过敏反应
本研究探讨α-半乳糖综合征(AGS)患者对常见医疗产品(包括心脏补片和生物瓣膜)的体外IgE反应。结果显示AGS血清对所有测试的非人源商业产品(包括脱细胞心脏补片和生物主动脉瓣)呈强反应性,而对α-半乳糖敲除猪制备的组织无反应。尽管经过商业脱细胞处理,动物源医疗产品中仍存在α-半乳糖,可能对接受心脏手术的致敏患者产生严重影响。
要点
- AGS患者血清对脱细胞心脏补片和生物瓣膜呈强IgE反应
- α-半乳糖敲除猪组织不引起AGS血清反应
- 商业脱细胞不能完全去除动物源产品中的α-半乳糖
核心结论
- AGS患者血清在体外对包括生物瓣膜在内的动物源医疗产品显示强亲和力,可能对接受心脏手术的致敏患者有严重潜在影响。
研究设计与样本
- 应用免疫印迹和免疫组化技术评估AGS患者对多种哺乳动物来源组织和医疗产品的IgE反应性。
主要发现
- AGS血清对所有测试的非人源商业产品(包括各种脱细胞心脏补片材料和生物主动脉瓣)显示强反应性。
- AGS血清对α-半乳糖敲除猪制备的组织无反应。
临床怎么用
- 对于AGS患者,选择心脏手术所用生物材料时需考虑α-半乳糖致敏可能带来的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Galactose-α-1,3-galactose (alpha-gal) is a carbohydrate that is ubiquitously expressed in all mammals except for primates and humans. Patients can become sensitized to this antigen and develop alpha-gal syndrome (AGS), or a red meat allergy. Symptoms range from generalized gastroenteritis and malaise to anaphylaxis, and in endemic areas, the prevalence can be as high as 20%. Although AGS patients commonly avoid alpha-gal by avoiding meat, patients have also developed symptoms due to animal-derived medical products and devices. With the rise in transcatheter aortic valve replacement, we investigate the immunogenicity of common cardiac materials and valves. OBJECTIVE: To assess the in vitro immunoglobulin E response toward common medical products, including cardiac patch materials and bioprosthetic valves in patients with AGS. METHODS: Immunoblot and immunohistochemistry techniques were applied to assess immunoglobulin E reactivity to various mammalian derived tissues and medical products for patients with AGS. RESULTS: AGS serum showed strong reactivity to all of the commercially available, nonhuman products tested, including various decellularized cardiac patch materials and bioprosthetic aortic valves. AGS serum did not react to tissues prepared using alpha-gal knockout pigs. CONCLUSIONS: Despite commercial decellularization processes, alpha-gal continues to be present in animal-derived medical products, including bioprosthetic valves. Serum from patients with AGS demonstrates a strong affinity for these products in vitro. This may have serious potential implications for sensitized patients undergoing cardiac surgery, including early valve failure and accelerated coronary artery disease.
引用
- Kuravi KV, Sorrells LT, Nellis JR, et al. Allergic response to medical products in patients with alpha-gal syndrome. J Thorac Cardiovasc Surg. 2021. PMID: 33933257. doi:10.1016/j.jtcvs.2021.03.100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。